Neonatal-onset Multisystem Inflammatory Disease with Nomid
📧 Sign up to get email alerts when something new happens for Neonatal-onset Multisystem Inflammatory Disease with Nomid.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease [Phase 3]
Phase 3 trial of canakinumab for neonatal-onset multisystem inflammatory disease (NOMID/CINCA) was terminated; results posted.